8-101492746-C-G

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_024915.4(GRHL2):​c.-24C>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.99 in 1,612,880 control chromosomes in the GnomAD database, including 791,254 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.99 ( 74236 hom., cov: 32)
Exomes 𝑓: 0.99 ( 717018 hom. )

Consequence

GRHL2
NM_024915.4 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 3.18

Publications

12 publications found
Variant links:
Genes affected
GRHL2 (HGNC:2799): (grainyhead like transcription factor 2) The protein encoded by this gene is a transcription factor that can act as a homodimer or as a heterodimer with either GRHL1 or GRHL3. Defects in this gene are a cause of non-syndromic sensorineural deafness autosomal dominant type 28 (DFNA28).[provided by RefSeq, Mar 2009]
GRHL2-DT (HGNC:55466): (GRHL2 divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.39).
BP6
Variant 8-101492746-C-G is Benign according to our data. Variant chr8-101492746-C-G is described in ClinVar as Benign. ClinVar VariationId is 508097.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.993 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_024915.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRHL2
NM_024915.4
MANE Select
c.-24C>G
5_prime_UTR
Exon 1 of 16NP_079191.2Q6ISB3-1
GRHL2
NM_001330593.2
c.-132C>G
5_prime_UTR
Exon 1 of 16NP_001317522.1Q6ISB3-2
GRHL2
NM_001440447.1
c.-24C>G
5_prime_UTR
Exon 1 of 16NP_001427376.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRHL2
ENST00000646743.1
MANE Select
c.-24C>G
5_prime_UTR
Exon 1 of 16ENSP00000495564.1Q6ISB3-1
GRHL2
ENST00000472106.2
TSL:1
n.305C>G
non_coding_transcript_exon
Exon 1 of 2
GRHL2
ENST00000907653.1
c.-24C>G
5_prime_UTR
Exon 1 of 14ENSP00000577712.1

Frequencies

GnomAD3 genomes
AF:
0.987
AC:
150202
AN:
152204
Hom.:
74191
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.998
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.929
Gnomad ASJ
AF:
1.00
Gnomad EAS
AF:
0.900
Gnomad SAS
AF:
0.965
Gnomad FIN
AF:
0.995
Gnomad MID
AF:
0.997
Gnomad NFE
AF:
0.999
Gnomad OTH
AF:
0.986
GnomAD2 exomes
AF:
0.969
AC:
241444
AN:
249050
AF XY:
0.973
show subpopulations
Gnomad AFR exome
AF:
0.998
Gnomad AMR exome
AF:
0.871
Gnomad ASJ exome
AF:
1.00
Gnomad EAS exome
AF:
0.901
Gnomad FIN exome
AF:
0.995
Gnomad NFE exome
AF:
0.999
Gnomad OTH exome
AF:
0.984
GnomAD4 exome
AF:
0.990
AC:
1446647
AN:
1460558
Hom.:
717018
Cov.:
37
AF XY:
0.990
AC XY:
719603
AN XY:
726692
show subpopulations
African (AFR)
AF:
0.998
AC:
33378
AN:
33446
American (AMR)
AF:
0.878
AC:
39249
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
26129
AN:
26130
East Asian (EAS)
AF:
0.903
AC:
35826
AN:
39690
South Asian (SAS)
AF:
0.967
AC:
83357
AN:
86218
European-Finnish (FIN)
AF:
0.995
AC:
53141
AN:
53410
Middle Eastern (MID)
AF:
0.994
AC:
5728
AN:
5762
European-Non Finnish (NFE)
AF:
0.999
AC:
1110236
AN:
1110848
Other (OTH)
AF:
0.988
AC:
59603
AN:
60342
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
782
1564
2345
3127
3909
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21634
43268
64902
86536
108170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.987
AC:
150305
AN:
152322
Hom.:
74236
Cov.:
32
AF XY:
0.985
AC XY:
73324
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.998
AC:
41497
AN:
41590
American (AMR)
AF:
0.929
AC:
14215
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
3472
AN:
3472
East Asian (EAS)
AF:
0.900
AC:
4650
AN:
5166
South Asian (SAS)
AF:
0.966
AC:
4658
AN:
4824
European-Finnish (FIN)
AF:
0.995
AC:
10565
AN:
10620
Middle Eastern (MID)
AF:
0.997
AC:
293
AN:
294
European-Non Finnish (NFE)
AF:
0.999
AC:
67975
AN:
68034
Other (OTH)
AF:
0.982
AC:
2068
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
93
185
278
370
463
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
914
1828
2742
3656
4570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.995
Hom.:
13830
Bravo
AF:
0.981
Asia WGS
AF:
0.931
AC:
3238
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Corneal dystrophy, posterior polymorphous, 4 (2)
-
-
1
Autosomal dominant nonsyndromic hearing loss 28 (1)
-
-
1
Nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome (1)
-
-
1
not provided (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.39
CADD
Benign
21
DANN
Benign
0.92
PhyloP100
3.2
PromoterAI
-0.11
Neutral
Mutation Taster
=297/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs515622; hg19: chr8-102504974; API